美国食品药品监督管理局（FDA）正式批准了复宏汉霖和Organon & Co联合开发的两款生物类似药——Bildyos®（德诺单抗-Nxxp）和Bilprevda®（德诺单抗-Nxxp），这两款药物分别是Prolia（德诺单抗）和Xgeva（德诺单抗）的生物类似药。
美国食品药品监督管理局（FDA）正式批准了复宏汉霖和Organon & Co联合开发的两款生物类似药——Bildyos®（德诺单抗-Nxxp）和Bilprevda®（德诺单抗-Nxxp），这两款药物分别是Prolia（德诺单抗）和Xgeva（德诺单抗）的生物类似药。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.